Literature DB >> 8156647

Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning.

M V Cohen1, X M Yang, J M Downey.   

Abstract

Although ischemic preconditioning protects myocardium from infarction in isolated hearts and in anesthetized open-chest animals, its effects have not been examined in unanesthetized animals. Furthermore, it is unknown whether animals become tolerant to multiple episodes of ischemic preconditioning. Rabbits were chronically instrumented with a balloon occluder around a major branch of the left coronary artery for reversible coronary occlusion, a left atrial catheter for radioactive microsphere injections, ECG electrodes for monitoring of myocardial ischemia, and, in some cases, a carotid artery catheter for pressure measurements and timed withdrawal of reference arterial blood samples. Eight control rabbits underwent a 30-minute coronary occlusion and then 180 minutes of reperfusion. Five of the eight rabbits developed ventricular tachycardia or fibrillation during ischemia, and infarct size averaged 37.7 +/- 2.6% of the risk area. Eight rabbits experienced a 5-minute coronary occlusion and 10 minutes of reperfusion before the 30-minute occlusion. In these preconditioned animals, potentially fatal arrhythmias during ischemia were significantly reduced (one of eight, P < .05), and infarct size was much smaller (5.6 +/- 1.1%, P < .0001). The difference could not be explained by hemodynamics or collateral blood flow, which were nearly identical in the two groups. But when the 30-minute coronary occlusion was preceded by 40 to 65 five-minute occlusions during a 3- to 4-day period in seven animals, protection was markedly attenuated. Potentially lethal arrhythmias were very common, and infarct size averaged 26.5 +/- 2.9%, substantially larger than in rabbits with only one preconditioning occlusion (P < .0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8156647     DOI: 10.1161/01.res.74.5.998

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

Review 1.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  Three questions about preconditioning.

Authors:  M Connaughton; D J Hearse
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

3.  Oral nicorandil recaptures the waned protection from preconditioning in vivo.

Authors:  Efstathios K Iliodromitis; Philip Cokkinos; Anastasia Zoga; Ioulia Steliou; Agathi R Vrettou; Dimitrios Th Kremastinos
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved.

Authors:  Y Qiu; P Ping; X L Tang; S Manchikalapudi; A Rizvi; J Zhang; H Takano; W J Wu; S Teschner; R Bolli
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Preconditioning: a balanced perspective.

Authors:  K Przyklenk; R A Kloner
Journal:  Br Heart J       Date:  1995-12

6.  From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity.

Authors:  Peter Whittaker; Karin Przyklenk
Journal:  Dose Response       Date:  2014-10-20       Impact factor: 2.658

Review 7.  Therapeutic receptor targets of ischemic preconditioning.

Authors:  Ryan M Fryer; John A Auchampach; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

Review 8.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

Review 9.  Adenosine and cardioprotection during reperfusion--an overview.

Authors:  Martín Donato; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

10.  Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.

Authors:  M W Hashimi; J D Thornton; J M Downey; M V Cohen
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.